Swee Lin Chen Yi Mei

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

Jason A. Tye–Din, A. James M. Daveson, Gautam Goel et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 34 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

WEST MEETS EAST: PRELIMINARY RESULTS OF NARROW BAND IMAGING WITH OPTICAL MAGNIFICATION IN THE DIAGNOSIS OF COLORECTAL LESIONS: A MULTICENTER AUSTRALIAN STUDY USING THE MODIFIED SANO'S CLASSIFICATION

Rajvinder Singh, Nazree Nordeen, Swee Lin Chen Yi Mei et al. · Digestive Endoscopy · 2011 · 22 citations

Medicine, Oncology, Pathology +17

Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

A. James M. Daveson, Thomas M. Polasek, Jorma Isola et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 18 citations

Life Sciences, Pharmacokinetics, Pharmacology +10

Budesonide Induces Favourable Histologic and Symptomatic Recovery in Patients with Non-responsive and Refractory Coeliac Disease When Given in an Open Capsule Format

Daniel Saitta, Lee M Henneken, Pragalathan Apputhurai et al. · Digestive Diseases and Sciences · 2024 · 13 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15